Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Clomiphene citrate

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44336   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    10 result(s) found for: Clomiphene citrate. Displaying page 1 of 1.
    EudraCT Number: 2008-006372-29 Sponsor Protocol Number: BlockeelC Start Date*: 2008-11-28
    Sponsor Name:Blockeel Christophe
    Full Title: Among non-IVF patients undergoing ovulation induction with clomiphene citrate (Clomid® 50 mg) and having no reaction at day 13 of the cycle, does administration of an increased dose of clomiphene c...
    Medical condition: The purpose of the present study is to analyse prospectively if highly purified hMG compared with increased dose of clomiphene citrate has different outcomes in folliculogenesis in ovulation induct...
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: BE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2018-004604-20 Sponsor Protocol Number: AGO/2018/007 Start Date*: 2019-12-03
    Sponsor Name:Ghent University Hospital
    Full Title: Myo-inositol versus clomiphene citrate as first line treatment for ovulation induction in PCOS
    Medical condition: Polycystic ovary syndrome (PCOS)
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: BE (Completed)
    Trial results: View results
    EudraCT Number: 2020-005938-15 Sponsor Protocol Number: CloTASH-2021-2Version15.10.21 Start Date*: 2021-11-03
    Sponsor Name:Oslo University Hospital
    Full Title: Health risks and treatment of anabolic-androgenic steroid (AAS) induced hypogonadism among men – a pilot study exploring off-label use of clomiphene citrate to reduce symptoms of androgen deficienc...
    Medical condition: Anabolic androgenic steroid induced hypogonadism among men
    Disease:
    Population Age: Adults Gender: Male
    Trial protocol: NO (Completed)
    Trial results: (No results available)
    EudraCT Number: 2011-000439-10 Sponsor Protocol Number: UOE/01-2011 Start Date*: 2011-07-11
    Sponsor Name:AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
    Full Title: Effect of metformin and clomiphene in obese hypogonadal men with or without type 2 diabetes on plasma levels of testosterone and metabolic parameters
    Medical condition: obese subjects with type 2 diabetes and hypogonadism
    Disease: Version SOC Term Classification Code Term Level
    14.1 10027433 - Metabolism and nutrition disorders 10049746 Insulin-requiring type II diabetes mellitus LLT
    14.1 10014698 - Endocrine disorders 10021011 Hypogonadism male PT
    14.1 10027433 - Metabolism and nutrition disorders 10033307 Overweight PT
    Population Age: Adults Gender: Male
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2011-002173-33 Sponsor Protocol Number: CLOFA Start Date*: 2012-05-08
    Sponsor Name:Fundació Privada EUGIN
    Full Title: Impact of clomiphene citrate administration during the early luteal phase on endocrine profile in agonist triggered GnRH antagonist in vitro fertilization cycles
    Medical condition: Female infertility
    Disease: Version SOC Term Classification Code Term Level
    14.1 10038604 - Reproductive system and breast disorders 10016398 Female infertility LLT
    Population Age: Adults Gender: Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2004-000335-28 Sponsor Protocol Number: 25198 Start Date*: 2004-10-19
    Sponsor Name:Serono International SA
    Full Title: A phase IIIB/IV, open label study to assess the efficacy and safety of a pre-defined, fixed dose of Gonal-f® (Filled-by-Mass in a Prefilled Pen) based on subject baseline characteristics, for ovari...
    Medical condition: Stimulation of multifollicular development in patients undergoing superovulation for assisted reproductive technologies (ART) such as in vitro fertilisation (IVF), gamete intra-fallopian transfer (...
    Disease: Version SOC Term Classification Code Term Level
    7.0 10003539 PT
    Population Age: Adults Gender: Female
    Trial protocol: SE (Completed) AT (Completed) GB (Completed) ES (Completed) IT (Completed)
    Trial results: View results
    EudraCT Number: 2021-000941-42 Sponsor Protocol Number: FSD-IEQ-2021-03 Start Date*: 2021-07-06
    Sponsor Name:Fundacion Santiago Dexeus Font
    Full Title: The impact of the intensity of ovarian stimulation on embryo quality in predicted suboptimal responders. A randomized controlled trial.
    Medical condition: To compare the number of GQB and the morphokinetic parameters of early embryo development in infertile suboptimal patients undergoing two different intensities of ovarian stimulation, a milder appr...
    Disease: Version SOC Term Classification Code Term Level
    20.0 10038604 - Reproductive system and breast disorders 10021928 Infertility female PT
    21.0 10038604 - Reproductive system and breast disorders 10021926 Infertility PT
    20.0 10038604 - Reproductive system and breast disorders 10021930 Infertility NOS LLT
    20.0 10038604 - Reproductive system and breast disorders 10021929 Infertility male PT
    20.1 10038604 - Reproductive system and breast disorders 10016399 Female infertility (primary) LLT
    21.1 10038604 - Reproductive system and breast disorders 10039843 Secondary infertility (female) LLT
    Population Age: Adults Gender: Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2010-023534-23 Sponsor Protocol Number: EMR 200061-504 Start Date*: 2011-05-09
    Sponsor Name:Merck Serono S.A. - Geneva
    Full Title: A phase IIIB, multicentre, multinational, randomized, open-label trial to compare the efficacy and safety of ovarian stimulation with GONAL-f® day 1 to day 5 followed by Pergoveris® starting day 6 ...
    Medical condition: Fertility disorders
    Disease: Version SOC Term Classification Code Term Level
    12.1 10016398 Female infertility LLT
    12.1 10016399 Female infertility (primary) LLT
    Population Age: Adults Gender: Female
    Trial protocol: NL (Completed) SK (Completed) DE (Completed) FI (Completed) GB (Completed) DK (Completed) GR (Completed) IT (Completed)
    Trial results: View results
    EudraCT Number: 2007-002823-34 Sponsor Protocol Number: 27818 Start Date*: 2007-11-08
    Sponsor Name:Merck Serono International S.A
    Full Title: A phase II, multicentre, randomised, assessor.blinded, active-comparator, parallel-group dose finding trial to evaluate AS900672-Enriched versus follitropin alfa (GONAL-f) in oligo-anovulatory infe...
    Medical condition: oligoanovulatory infertile women who are candidates for ovulation induction (OI)
    Disease: Version SOC Term Classification Code Term Level
    9.1 10033312 Ovulation induction PT
    Population Age: Adults Gender: Female
    Trial protocol: SE (Prematurely Ended) FR (Completed) DE (Prematurely Ended) IT (Prematurely Ended) ES (Completed) DK (Completed) BE (Completed) NL (Prematurely Ended) GB (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2013-003817-16 Sponsor Protocol Number: EMR200061-005 Start Date*: 2014-02-05
    Sponsor Name:Merck KGaA
    Full Title: A phase III, randomized, controlled, single-blind, multicentre, parallel arm trial to assess the efficacy and safety of Pergoveris® (follitropin alfa and lutropin alfa) and GONAL-f® (follitropin...
    Medical condition: Poor Ovarian Response i.e. a failure to respond adequately to standard ART (assisted reproductive technologies) protocols and to recruit adequate follicles
    Disease: Version SOC Term Classification Code Term Level
    17.0 100000004872 10033140 Ovarian disorder NOS LLT
    Population Age: Adults Gender: Female
    Trial protocol: CZ (Completed) SE (Completed) EE (Completed) HU (Completed) BE (Completed) GB (Completed) NL (Completed) DK (Completed) LV (Completed) ES (Completed) PL (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Fri May 16 12:02:20 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA